Advertisement
Our latest volumes and outcomes data in these areas plus HOCM and pericarditis
Below we share recent volumes and clinical outcomes from a sampling of disciplines and subspecialty areas in Cleveland Clinic’s Miller Family Heart, Vascular & Thoracic Institute: thoracic surgery, lung transplantation, hypertrophic obstructive cardiomyopathy and pericarditis.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Number of general thoracic operations performed
Number of robotically assisted thoracic surgery procedures
Proportion of all lobectomies for stage I lung cancer (N = 120) that used video/robot-assisted thoracoscopic surgery
Proportion of thymectomy/thymic mass resections completed robotically (N = 33)
The following data and ratings are from the Society of Thoracic Surgeons (STS) General Thoracic Surgery Database (3-year period ending December 2023):
Total lung transplants performed, including 1 heart/lung and 5 lung/liver
Lung transplants performed after ex vivo lung perfusion (EVLP)
30-day survival rate following EVLP lung transplant
Outpatient visits for HOCM
New HOCM patients seen
Septal myectomy procedures (with or without other procedures) performed for HOCM
Observed-to-expected mortality ratio for septal myectomy*
Patients seen by our Pericardial Diseases Center
New patients seen by the Pericardial Diseases Center
Pericardial procedures performed
Pericardiectomies performed
Cleveland Clinic’s Heart, Vascular & Thoracic Institute has a long-established tradition of reporting volume and outcomes data across its various subspecialty areas. For more information like the data reported above, visit clevelandclinic.org/hvtioutcomes and clevelandclinic.org/e15.
Advertisement
Advertisement
Study finds important discrepancies among modalities and techniques
Serial strain assessments show sustained favorable impacts on LV systolic function and LA function
Exploring the cost-effectiveness of end-of-life treatment options
Offers recommendations on imaging and treatment across five clinical pericardial syndromes
The agent-based model aims to improve prediction accuracy
Logistic feasibility supported for treating obstructive HCM under the REMS program
Research explores how incorporating long-term benefits will impact the new U.S. lung transplant allocation system
Latest results confirm and build on 16-week findings